My professional life started in 1982 with the use of technology (pumps) in pediatric diabetes. It showed me the huge treatment challenges for children and families and the enigma of diabetes pathogenesi(e)s.

Clinical research is only possible when quality care is in place. When I came to Luxembourg, I supported the creation of the multidisciplinary Pediatric Diabetes&Endocrinology Team (DECCP/CHL) with a 24/7 care for children/families with all forms of diabetes and endocrine conditions. Our team has joined the ERN (European Reference Networks) ENDO as the first full ERN member in Luxembourg.

My three research pillars include Epidemiology and Benchmarking of care outcome (Eurodiab, DIAMOND, EUDIP, Hvidoere Study Group, SWEET), Innovative  treatment approaches, closing the loop (SWITCH, QUEST and KIDSAP) and better Understanding the pathomechanism(s) of T1DM (TRIGR, INNODIA).

In collaboration with the Luxemburg Ecosystems Group (P Wilmes, LCSB) we investigated the relationship between host and microbiome during early life (COSMIC) and disease (MUST). This led to new ideas. Further research is needed to investigate this interaction between evolving colonisation of the microbiome and its host in the infant to understand the contribution of the functional microbiome to the development of type 1 diabetes in the genetically at risk persons.

Between 2012 and 2016, I served as Secretary General of ISPAD.

It is my honour to serve currently as President (2020-2022) of this unique society. I’m guest professor at the Free University of Brussels, Belgium and the University of Luxembourg. I represent Luxembourg in the Paediatric Committee at   European Medicine Agency (PDCO/EMA).

ISPAD representative on the Steering Committee of GPED (Global Pediatric Endocrine and Diabetes consortium). Member in National Board of Directors of the American Diabetes Association.

Professional member of the American Association of Clinical Endocrinologist (AACE), the Lawson Wilkins Pediatric Endocrine Society (LWPES) and the Endocrine Society.

He was a co-investigator of the NIH-sponsored DCCT for ten years and also served on the American Academy of Pediatrics Endocrine Executive Committee and on the International Diabetes Federation’s Youth Section Consultative Section as well as its Youth Task Force. In addition to the AAP, ADA, ISPAD and IDF, he is a professional member of the American Association of Clinical Endocrinologists (AACE), the (Lawson Wilkins) Pediatric Endocrine Society (PES) and the Endocrine Society, previously was on the executive committee of GPED at its inception and serves currently on the PES International Relations Committee as well as the IDF Life for a Child advisory board. Dr Brink was ISPAD’s prestigious Lestradet Award winner in 2011 for international contributions for diabetes education and advocacy

Stuart Brink is Doctor Honoris Causa of the University of Medicine and Pharmacy “Victor Babes” Timisoara.

2016 – Honorary Citizen of Timisoara.

Honors Diploma from Veliko Tarnova Municipality in Bulgaria as well as the ADA’s Outstanding Contribution to Diabetes in Youth award and the JDF’s Anne Woolf award. He has taught about pediatric and adolescent diabetes and pediatric endocrinology in more than 60 countries around the world.

He is Head of the Department of Paediatrics at the University Hospital in Chieti since 1994.

Professor Chiarelli is a clinician with clinical and research interests in diabetes, obesity and growth disorders. His main research fields have been the prediction and prevention of type 1 diabetes, microvascular diabetes complications in children and growth disorders. His other clinical interests are obesity and metabolic syndrome. He was the leader of the first International Consensus Statement on ”Insulin Resistance in Children”, published on Journal of Clinical Endocrinology and Metabolism (JCEM) in 2010.

He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 2004 to 2011 and President of ESPE in 2009 (Annual Meeting in New York, USA) and 2013 (Annual Meeting in Milan, Italy). He was also President of the Italian Society for Paediatric Research from 2012 to 2015.

He is a Consultant of the World Health Organisation (WHO) for Non-Communicable Diseases (NCD) in children (2016-2022).

Professor Chiarelli has lectured in 78 countries world-wide and has published over 700 original articles, reviews, textbook chapters and books (H-index 65, over 6,000 citations). In 2015, he was the youngest awardee of the ESPE Andrea Prader Prize for contributions to paediatric endocrinology.

Current position is Chair of Central German Network for rare disease
Professional education and work
2001 – 2018: Head of center for neonatal screening Saxony_Anhalt
2010: extraordinary Professor at Department Pediatrics, Otto-von-Guericke University Magdeburg, Germany.
Relevant Job Training:
– Research on insulin receptor ontogenesis at Inst Biology Semmelweis University Budapest / Hungary
– Fellowship on hypoglycemia and congenital Hyperinsulinism at Institute Child health, Newcastle, UK
– Research project at Department Pediatrics and Department Cell Anatomy, MUSC Charleston
He is a professional member of the German working group for Pediatric Endocrinology, member of the European Society for Pediatric Endocrinology (ESPE), member of the German Society for Endocrinology (DGE), member of the German Society for Pediatrics (DGKJ),
– Since 2008: Vice-Chair of German Association for people with short stature and their families (BKMF)
– Vice-Chair of German Association for centers of rare diseases (2014-2020)
– Chair of Saxonian-Thuringian society for Pediatrics and Pediatric Surgery (STGKJM)
– Since 2014 Chair of the COACH consortium (Collaborative Alliance on Congenital Hyperinsulinism)
– 2017 – ongoing: Chair of Central German Network for rare disease (MKSE), member of ENDO-ERN, Metab-ERN, BOND-ERN (European certified centers for rare disease), chair of HCP OvGU.
Research areas of interest and Prices
– Genetic and pathogenetic basis of endocrine and metabolic diseases, with special interest in congenital hyperinsulinism. Clinical Care guidelines and quality assurance in pediatric endocrine diseases (CAH, Congenital Hypothyroidism
– Pediatric clinical trials
– 2008 Henning-Andersen Award of the European Society for Pediatric Endocrinology (ESPE) for epidemiology research project in congenital hyperinsulinism
– 2009 Hormone Research Price (ESPE) for “Novel insights in congenital hyperinsulinism
Has published over 100 original articles